COVID-19 and the gut
Health COVID-19 and the gut

COVID-19 and the gut Researchers summarize current knowledge about underlying mechanisms and potential therapeutic approaches for the effects of COVID-19 on the gut.

read more
Exposure to e-cigarette aerosols can cause heart arrhythmias, study shows
Health Exposure to e-cigarette aerosols can cause heart arrhythmias, study shows

Exposure to e-cigarette aerosols can cause heart arrhythmias, study shows A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute has found that exposure to e-cigarette aerosols can cause heart arrhythmias in animal models -; both in the form of premature and skipped heart beats.

read more
Overexpression of KIF11 gene may offset Alzheimer’s-related cognitive decline in mice and humans
Health Overexpression of KIF11 gene may offset Alzheimer’s-related cognitive decline in mice and humans

Overexpression of KIF11 gene may offset Alzheimer’s-related cognitive decline in mice and humans The overexpression of a gene tied to cell division and the structure and function of neurons may prevent and protect against cognitive decline in both mice and humans with Alzheimer’s disease (AD), according to a new study by scientists at the University of Colorado Anschutz Medical Campus.

read more
Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer
Health Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer

Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free survival (PFS) in patients with oligometastatic prostate cancer.

read more
New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models
Health New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models A new approach to cancer immunotherapy that uses one type of immune cell to kill another-;rather than directly attacking the cancer-;provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers at the Icahn School of Medicine at Mount Sinai in New York.

read more

About Me

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.

Know More

Tag

Social

Join Our Newsletter

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero